RxDoctor Payments Data

Shearwood McClelland, MD

Neurological Surgery · Minneapolis, MNNPI 1750573127

Payments from drug & device makers

What this record shows

Icotec Medical Inc. accounts for 72.5% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $2,699, more than ten times the $103 reported in 2019.

$3,366in general payments, 2019–2025

Across 22 payments — averaging $153.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Icotec Medical Inc.$2K
  • Novocure Inc.$637
  • Novartis$133
  • Gilead$128
  • Incyte Corporation$28
$180,000in research payments, 2019–2025

Across 2 payments — averaging $90,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$180K

What the payments were for

  • Travel & lodging$1,78553%
  • Food & beverage$1,58147%

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Icotec Medical Inc.12$2,440
Novocure Inc.7$637
Novartis1$133
Gilead1$128
Incyte Corporation1$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,366 in reported general payments places this provider in the 65th percentile of 140 neurological surgery providers in Minnesota.

See all neurological surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$2,158
Medicare patients
25
Services billed
35

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →